(Q37532050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ian M. Adcock

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Gaetano Caramori

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

1 reference

26 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

853-871

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19557399%20AND%20SRC:MED&resulttype=core&format=json

beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Cellular and structural bases of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Inhaled flunisolide for acute severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0682-Z

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

21 January 2018

1 reference

12 December 2020

Regulatory T cells and IL-10 in allergic inflammation

1 reference

12 December 2020

Effects of montelukast and beclomethasone on airway function and asthma control

1 reference

12 December 2020

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

1 reference

12 December 2020

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

12 December 2020

Nuclear receptors: doubling up in the lung

1 reference

12 December 2020

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

12 December 2020

Oxidative stress and redox regulation of lung inflammation in COPD.

1 reference

12 December 2020

Effect of inhaled glucocorticoids on IL-1 beta and IL-1 receptor antagonist (IL-1 ra) expression in asthmatic bronchial epithelium

1 reference

12 December 2020

Epithelial cell proliferation contributes to airway remodeling in severe asthma

1 reference

12 December 2020

Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients

1 reference

12 December 2020

Airway structural alterations selectively associated with severe asthma.

1 reference

12 December 2020

Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years

1 reference

12 December 2020

Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma

1 reference

12 December 2020

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

1 reference

12 December 2020

An overview of glucocorticoid anti-inflammatory actions

1 reference

12 December 2020

The effects of glucocorticoids on human eosinophils

1 reference

12 December 2020

Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group

1 reference

12 December 2020

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

12 December 2020

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

12 December 2020

Designing corticosteroid drugs for pulmonary selectivity

1 reference

12 December 2020

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

1 reference

12 December 2020

Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma

1 reference

12 December 2020

Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis

1 reference

12 December 2020

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

1 reference

12 December 2020

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

1 reference

12 December 2020

Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease.

1 reference

12 December 2020

Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects

1 reference

12 December 2020

Steroid receptor phosphorylation: a key modulator of multiple receptor functions

1 reference

12 December 2020

The dose-response characteristics of inhaled corticosteroids when used to treat asthma: an overview of Cochrane systematic reviews

1 reference

12 December 2020

Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

12 December 2020

Systematic assessment of difficult-to-treat asthma

1 reference

12 December 2020

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

12 December 2020

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

12 December 2020

Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values

1 reference

12 December 2020

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

12 December 2020

A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

1 reference

12 December 2020

Messenger RNA turnover in eukaryotes: pathways and enzymes

1 reference

12 December 2020

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

1 reference

12 December 2020

Effect of High Dose Inhaled Steroid on Cells, Cytokines, and Proteases in Induced Sputum in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Fluticasone at different doses for chronic asthma in adults and children

1 reference

12 December 2020

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

12 December 2020

Systemic inflammation and mortality in chronic obstructive pulmonary disease

1 reference

12 December 2020

Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients

1 reference

12 December 2020

Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression

1 reference

12 December 2020

Long-term effects of budesonide on inflammatory status in COPD.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide

1 reference

12 December 2020

Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone

1 reference

12 December 2020

Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients

1 reference

12 December 2020

Lung function and asthma control with beclomethasone and formoterol in a single inhaler

1 reference

12 December 2020

Fiberoptic bronchoscopy and bronchial mucosal biopsies in asthmatics undergoing long-term high-dose budesonide aerosol treatment

1 reference

12 December 2020

Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma

1 reference

12 December 2020

Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom

1 reference

12 December 2020

Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal

1 reference

12 December 2020

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

12 December 2020

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

1 reference

12 December 2020

The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial

1 reference

12 December 2020

Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma

1 reference

12 December 2020

Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids

1 reference

12 December 2020

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

12 December 2020

Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment

1 reference

12 December 2020

Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor

1 reference

12 December 2020

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

1 reference

12 December 2020

How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids.

1 reference

12 December 2020

Inhaled glucocorticoids for asthma

1 reference

12 December 2020

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

12 December 2020

Is there an association between inhaled corticosteroids and bone density in postmenopausal women?

1 reference

12 December 2020

Early use of inhaled corticosteroids in the emergency department treatment of acute asthma

1 reference

12 December 2020

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

1 reference

12 December 2020

Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization

1 reference

12 December 2020

Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.

1 reference

12 December 2020

Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing

1 reference

12 December 2020

Reduction of budesonide after a year of increased use: a randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintained

1 reference

12 December 2020

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

1 reference

12 December 2020

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

1 reference

12 December 2020

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations

1 reference

12 December 2020

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

1 reference

12 December 2020

Vascularity in asthmatic airways: relation to inhaled steroid dose

1 reference

12 December 2020

Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.

1 reference

12 December 2020

Role of dual specificity phosphatases in biological responses to glucocorticoids.

1 reference

12 December 2020

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

1 reference

12 December 2020

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

12 December 2020

Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases

1 reference

12 December 2020

Clinical safety of inhaled corticosteroids for asthma in children: an update of long-term trials

1 reference

12 December 2020

Comparative effects of inhaled budesonide and the NO-donating budesonide derivative, NCX 1020, against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge

1 reference

12 December 2020

Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD

1 reference

12 December 2020

Inhaled steroids and mortality in COPD: bias from unaccounted immortal time.

1 reference

12 December 2020

Chronic obstructive pulmonary disease

1 reference

12 December 2020

Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

1 reference

12 December 2020

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

1 reference

12 December 2020

Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

1 reference

12 December 2020

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma

1 reference

12 December 2020

Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease

1 reference

12 December 2020

Review: individual DMARDs have similar efficacy for RA, but combination therapy improves response

1 reference

12 December 2020

Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone

1 reference

12 December 2020

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care

1 reference

12 December 2020

Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults

1 reference

12 December 2020

Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients

1 reference

12 December 2020

Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma

1 reference

12 December 2020

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

1 reference

12 December 2020

Long-term effects of budesonide or nedocromil in children with asthma.

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

Parameters associated with persistent airflow obstruction in chronic severe asthma

1 reference

12 December 2020

The pharmacologic control of mediator release from human basophils and mast cells

1 reference

12 December 2020

Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model

1 reference

12 December 2020

Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma

1 reference

12 December 2020

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

1 reference

12 December 2020

Role of inflammation in the hyperreactivity of the airways in asthma

1 reference

12 December 2020

Effect of corticosteroids on airway hyperresponsiveness

1 reference

12 December 2020

Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease

1 reference

12 December 2020

Neutrophilic inflammation in severe persistent asthma

1 reference

12 December 2020

1 reference

12 December 2020

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

12 December 2020

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

12 December 2020

Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

1 reference

12 December 2020

Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study

1 reference

12 December 2020

Corticosteroid reversibility in COPD is related to features of asthma

1 reference

12 December 2020

Inhaled corticosteroids in chronic obstructive pulmonary disease

1 reference

12 December 2020

Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism

1 reference

12 December 2020

Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects

1 reference

12 December 2020

Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate

1 reference

12 December 2020

Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma

1 reference

12 December 2020

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

1 reference

12 December 2020

An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils

1 reference

12 December 2020

Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis

1 reference

12 December 2020

Pharmacological strategies for self-management of asthma exacerbations.

1 reference

12 December 2020

High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study

1 reference

12 December 2020

Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.

1 reference

12 December 2020

Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma

1 reference

12 December 2020

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial

1 reference

12 December 2020

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

1 reference

12 December 2020

The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects

1 reference

12 December 2020

Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

1 reference

12 December 2020

Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue

1 reference

12 December 2020

Adrenal crisis due to inhaled steroids is underestimated

1 reference

12 December 2020

Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma

1 reference

12 December 2020

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

1 reference

12 December 2020

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

1 reference

12 December 2020

The nature of small-airway obstruction in chronic obstructive pulmonary disease

1 reference

12 December 2020

Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease

1 reference

12 December 2020

Inhaled corticosteroid use and bone-mineral density in patients with asthma

1 reference

12 December 2020

Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study

1 reference

12 December 2020

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

1 reference

12 December 2020

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture

1 reference

12 December 2020

The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persiste

1 reference

12 December 2020

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.

1 reference

12 December 2020

Specificity of basement membrane thickening in severe asthma

1 reference

12 December 2020

The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

12 December 2020

Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids

1 reference

12 December 2020

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.

1 reference

12 December 2020

Use of inhaled corticosteroids and risk of fractures.

1 reference

12 December 2020

Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-me

1 reference

12 December 2020

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

1 reference

12 December 2020

Update on glucocorticoid action and resistance

1 reference

12 December 2020

Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungs

1 reference

12 December 2020

Effects of budesonide and fluticasone on 24-hour plasma cortisol. A dose-response study

1 reference

12 December 2020

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

1 reference

12 December 2020

Contemporary management of chronic obstructive pulmonary disease: scientific review

1 reference

12 December 2020

p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma

1 reference

12 December 2020

Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma

1 reference

12 December 2020

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

12 December 2020

Overcoming steroid insensitivity in smoking asthmatics.

1 reference

12 December 2020

A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid

1 reference

12 December 2020

Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma

1 reference

12 December 2020

Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes.

1 reference

12 December 2020

Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

1 reference

12 December 2020

Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.

1 reference

12 December 2020

New targets for drug development in asthma

1 reference

12 December 2020

Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down

1 reference

12 December 2020

Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes

1 reference

12 December 2020

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial

1 reference

12 December 2020

Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma

1 reference

12 December 2020

Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis

1 reference

12 December 2020

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

12 December 2020

Molecular mechanisms of corticosteroid resistance.

1 reference

12 December 2020

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

1 reference

12 December 2020

Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients

1 reference

12 December 2020

Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients

1 reference

12 December 2020

Effects of inhaled glucocorticoids on bone density in premenopausal women

1 reference

12 December 2020

Daily versus as-needed corticosteroids for mild persistent asthma

1 reference

12 December 2020

Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.

1 reference

12 December 2020

Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile

1 reference

12 December 2020

Increased activation of p38 MAPK in COPD

1 reference

12 December 2020

Mechanisms involved in the side effects of glucocorticoids

1 reference

12 December 2020

The role of chromatin during transcription

1 reference

12 December 2020

The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge

1 reference

12 December 2020

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

1 reference

12 December 2020

Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.

1 reference

12 December 2020

Molecular interactions between glucocorticoids and long-acting beta2-agonists.

1 reference

12 December 2020